Proteostasis Therapeutics Inc (PTI) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Proteostasis Therapeutics Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
PTI Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Proteostasis Therapeutics Inc's percent of analysts bearish on the stock is less than nearly 100% of all US stocks.
- PTI has a greater average analyst price target than 4.69% of all US stocks.
- PTI has a higher upside potential (average analyst target price relative to current price) than 90.5% of all US stocks.
- Proteostasis Therapeutics Inc's variance in analysts' estimates is less than 14.18% of stocks in the small market cap category.
- Proteostasis Therapeutics Inc's number of analysts covering the stock is greater than 14.51% of Pharmaceutical Products stocks.
- PTI has a higher percentage of analysts bullish on the stock than 81.97% of all US stocks.
- The change in bullishness amongst analysts of PTI is less than nearly 100% of all US stocks.
Make investment decisions regarding PTI using the data that counts. Try POWR Ratings for free.